Vertex Pharmaceuticals Inc / Ma

Kovitz Investment Group Partners, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/20/2026

Shares

98,375

Value ($000)

44,600

Weight

1.0%

2020 Q3 - 2025 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/20/2026	44,600	1.0%	98,375	12/31/2025
2025 Q3	11/10/2025	31,561	0.1%	80,587	9/30/2025
2025 Q2	8/14/2025	14,266	0.1%	32,043	6/30/2025
2025 Q1	5/19/2025	4,106	0.0%	8,469	3/31/2025
2024 Q4	8/25/2025	6,920	0.0%	17,181	12/31/2024
2024 Q3	11/15/2024	15,433	0.1%	36,083	9/30/2024
2024 Q2	8/14/2024	14,741	0.1%	31,445	6/30/2024
2024 Q1	5/14/2024	670	0.0%	1,602	3/31/2024
2021 Q4	2/4/2022	739	0.0%	3,128	12/31/2021
2021 Q3	10/28/2021	1,676	0.0%	9,238	9/30/2021
2021 Q2	8/4/2021	2,351	0.0%	11,658	6/30/2021
2021 Q1	5/6/2021	1,207	0.0%	5,618	3/31/2021
2020 Q4	2/12/2021	739	0.0%	3,128	12/31/2020
2020 Q3	11/10/2020	1,289	0.0%	4,738	9/30/2020